Nissan Chemical Corporation logo

Nissan Chemical Corporation

4021.T

JPXBasic MaterialsChemicals

Latest quote

¥8,069

+¥91.00 · +1.14%

Aug 24, 3:30 PM JST

4021.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Founded in Tokyo in 1887, Nissan Chemical Corporation conducts its diverse business operations both domestically in Japan and across international markets, specializing in four key areas: chemicals, performance materials, agricultural chemicals, and pharmaceuticals. The company's expansive chemical product line includes the adhesive agent MELAMINE, a variety of high-purity chemicals, the urea solution AdBlue, and foundational industrial compounds such as ammonia, sulfuric acid, and nitric acid. Other specialized chemical offerings feature TEPIC (an epoxy compound), Melamine Cyanurate (a salt of melamine and isocyanuric acid), phenylphosphonic acid, and HI-LITE (a chlorinated isocyanurate). Additionally, Nissan Chemical manufactures the health food Nissan Reishi, OPTBEADS (composed of melamine-formaldehyde resin and silica), and FINEOXOCOL (a saturated fatty alcohol and acid). Within its performance materials division, the corporation develops crucial materials for display technologies, semiconductors, and various inorganic applications. Its agricultural chemicals segment supplies a broad range of products, including herbicides, insecticides, and fungicides, utilized on farmlands, golf courses, and public parks. This division also produces active pharmaceutical ingredients for animal antiparasitic medications. In the pharmaceutical sector, Nissan Chemical markets prescription drugs such as LIVALO, which is used to reduce cholesterol, and LANDEL and FINTE, both dual-action calcium channel blockers. Beyond its proprietary pharmaceutical products, the company offers custom manufacturing and process research services for pharmaceutical ingredients. Looking towards future innovation, Nissan Chemical is actively engaged in developing solutions across healthcare, information and communication materials, and environmental and energy materials. The company, which was previously known as Nissan Chemical Industries, Ltd., officially changed its name to Nissan Chemical Corporation in July 2018.

Industry
Chemicals
Sector
Basic Materials
Headquarters
JP
CEO
Kojiro Kinoshita
Listed since
Jan 4, 2000
Employees
3,411

Market position

52-week range

Current ¥8,069

Open
¥8,069
Previous close
¥7,978
Volume
0
0× average
Average volume
676.42K
Average daily volume
Market cap
1.08T JPY
Beta
0.45
Market reference 1
50-day average
¥7,955.54
+1.43% above average
200-day average
¥6,570.83
+22.80% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
811.91B JPY
P/E (TTM)
20.59×
P/B (TTM)
4.3×
P/S (TTM)
3.75×
EV / EBITDA
9.92×
Earnings yield
6.14%
Free cash flow yield
5.59%
Dividend yield
2.50%

Profitability & efficiency

Gross margin
47.37%
Operating margin
23.35%
Net margin
18.25%
Return on equity
19.47%
Return on assets
14.00%
Return on invested capital
15.98%

Financial health

Debt / equity
0.18×
Current ratio
2.84×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends50%38%26%14%Gross margin, FY2022: 46.76%Gross margin, FY2023: 45.04%Gross margin, FY2024: 44.31%Gross margin, FY2025: 45.09%Gross margin, FY2026: 46.83%Operating margin, FY2022: 24.50%Operating margin, FY2023: 22.93%Operating margin, FY2024: 21.26%Operating margin, FY2025: 22.61%Operating margin, FY2026: 22.73%Net margin, FY2022: 18.65%Net margin, FY2023: 18.02%Net margin, FY2024: 16.78%Net margin, FY2025: 17.12%Net margin, FY2026: 17.78%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 46.76%. Gross margin FY2023 45.04%. Gross margin FY2024 44.31%. Gross margin FY2025 45.09%. Gross margin FY2026 46.83%. Operating margin FY2022 24.50%. Operating margin FY2023 22.93%. Operating margin FY2024 21.26%. Operating margin FY2025 22.61%. Operating margin FY2026 22.73%. Net margin FY2022 18.65%. Net margin FY2023 18.02%. Net margin FY2024 16.78%. Net margin FY2025 17.12%. Net margin FY2026 17.78%.

Income trends

Revenue

279.59B JPY+11.23%

Operating income

63.55B JPY+11.82%

Net income

49.71B JPY+15.49%
Income trends across reported periods303.74B JPY207.12B JPY110.5B JPY13.88B JPYRevenue, FY2022: 207.97B JPYRevenue, FY2023: 228.07B JPYRevenue, FY2024: 226.71B JPYRevenue, FY2025: 251.37B JPYRevenue, FY2026: 279.59B JPYOperating income, FY2022: 50.96B JPYOperating income, FY2023: 52.28B JPYOperating income, FY2024: 48.2B JPYOperating income, FY2025: 56.83B JPYOperating income, FY2026: 63.55B JPYNet income, FY2022: 38.78B JPYNet income, FY2023: 41.09B JPYNet income, FY2024: 38.03B JPYNet income, FY2025: 43.04B JPYNet income, FY2026: 49.71B JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 207.97B JPY. Revenue FY2023 228.07B JPY. Revenue FY2024 226.71B JPY. Revenue FY2025 251.37B JPY. Revenue FY2026 279.59B JPY. Operating income FY2022 50.96B JPY. Operating income FY2023 52.28B JPY. Operating income FY2024 48.2B JPY. Operating income FY2025 56.83B JPY. Operating income FY2026 63.55B JPY. Net income FY2022 38.78B JPY. Net income FY2023 41.09B JPY. Net income FY2024 38.03B JPY. Net income FY2025 43.04B JPY. Net income FY2026 49.71B JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue279.59B JPY251.37B JPY226.71B JPY228.07B JPY207.97B JPY
Cost of goods sold148.65B JPY138.03B JPY126.24B JPY125.33B JPY110.73B JPY
Gross profit130.94B JPY113.34B JPY100.46B JPY102.73B JPY97.24B JPY
Research and development21.38B JPY17.58B JPY17.33B JPY16.84B JPY16.02B JPY
Selling, general, and administrative56.3B JPY38.93B JPY34.93B JPY33.61B JPY30.26B JPY
Operating expenses67.39B JPY56.51B JPY52.26B JPY50.45B JPY46.28B JPY
Interest income178M JPY217M JPY161M JPY203M JPY49M JPY
Interest expense396M JPY709M JPY526M JPY252M JPY73M JPY
Depreciation and amortization15.51B JPY14.37B JPY13.8B JPY10.98B JPY10.22B JPY
Operating income63.55B JPY56.83B JPY48.2B JPY52.28B JPY50.96B JPY
Net income49.71B JPY43.04B JPY38.03B JPY41.09B JPY38.78B JPY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
64%
7 beats, 4 misses, 0 met estimates
Average EPS surprise
+5.98%
11 comparable reports
Latest EPS result
125.74
Estimate 110.72 · Beat by 13.57%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates130.77106.7482.758.67Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 81.49, estimate 63.7, surprise +27.93%, Beat. Q2 2025, reported May 15, 2025: actual 82.99, estimate 80.63, surprise +2.93%, Beat. Q3 2025, reported Aug 8, 2025: actual 102.2, estimate 81.83, surprise +24.89%, Beat. Q4 2025, reported Nov 10, 2025: actual 66.25, estimate 70.35, surprise -5.83%, Miss. Q1 2026, reported Feb 9, 2026: actual 90.65, estimate 73.47, surprise +23.38%, Beat. Q2 2026, reported May 15, 2026: actual 109.28, estimate 104, surprise +5.08%, Beat. Q3 2026, reported Aug 7, 2026: actual 125.74, estimate 110.72, surprise +13.57%, Beat. Q4 2026, reported Nov 6, 2026: actual —, estimate 82.09, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates87.62B75.05B62.48B49.9BQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 7, 2025: actual 56.65B JPY, estimate 53.27B JPY, surprise +6.33%, Beat. Q2 2025, reported May 15, 2025: actual 76.53B JPY, estimate 73.05B JPY, surprise +4.77%, Beat. Q3 2025, reported Aug 8, 2025: actual 69.87B JPY, estimate 62.9B JPY, surprise +11.08%, Beat. Q4 2025, reported Nov 10, 2025: actual 60.22B JPY, estimate 57.44B JPY, surprise +4.85%, Beat. Q1 2026, reported Feb 9, 2026: actual 65.34B JPY, estimate 58.12B JPY, surprise +12.42%, Beat. Q2 2026, reported May 15, 2026: actual 84.25B JPY, estimate 81.72B JPY, surprise +3.09%, Beat. Q3 2026, reported Aug 7, 2026: actual 78.79B JPY, estimate 70.98B JPY, surprise +11.00%, Beat. Q4 2026, reported Nov 6, 2026: actual —, estimate 64.92B JPY, surprise —, Comparison unavailable.

4021.T peers

ETFs holding 4021.T

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research 4021.T

research.disclaimer